EUROEYES INTERNATIONAL EYE CLINIC LIMITED EuroEyes International Eye Clinic Limited Stock
Equities
1846
KYG3224D1088
Healthcare Facilities & Services
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.95 HKD | +3.12% |
|
+5.54% | -4.99% |
| Apr. 26 | EuroEyes International to Buy Back Up to 3% Shares | MT |
| Apr. 24 | EuroEyes International Logs 6% Growth in Q1 Eye Surgeries | MT |
| Sales 2023 | 714M 91.24M | Sales 2024 * | 874M 112M | Capitalization | 1.65B 211M |
|---|---|---|---|---|---|
| Net income 2023 | 131M 16.73M | Net income 2024 * | 201M 25.68M | EV / Sales 2023 | 2.43 x |
| Net cash position 2023 * | - 0 | Net cash position 2024 * | - 0 | EV / Sales 2024 * | 1.89 x |
| P/E ratio 2023 |
13.2
x | P/E ratio 2024 * |
8.25
x | Employees | 353 |
| Yield 2023 * |
2.22% | Yield 2024 * |
2.83% | Free-Float | 41.1% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | +3.13% | ||
| 1 week | +5.54% | ||
| Current month | +7.38% | ||
| 1 month | +12.76% | ||
| 3 months | +1.02% | ||
| 6 months | +12.50% | ||
| Current year | -4.99% |
1 week
4.75
4.95
1 month
4.504.95
Current year
4.315.29
1 year
4.155.92
3 years
4.0814.90
5 years
3.6515.18
10 years
3.6515.18
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 69 | 92-12-31 | |
Markus Braun
DFI | Director of Finance/CFO | 50 | 18-09-30 |
| Chief Operating Officer | 56 | 05-02-28 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Marcus Bracklo
BRD | Director/Board Member | 58 | 12-06-30 |
Hans Hennig
BRD | Director/Board Member | 66 | 19-03-24 |
| Chief Executive Officer | 69 | 92-12-31 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-26 | 4.95 | +3.13% | 126,000 |
| 24-04-25 | 4.8 | 0.00% | 6,000 |
| 24-04-24 | 4.8 | +1.05% | 26,000 |
| 24-04-23 | 4.75 | -1.86% | 18,000 |
| 24-04-22 | 4.84 | +3.20% | 12,000 |
Delayed Quote Hong Kong S.E., April 26, 2024 at 04:08 am EDT
More quotes
Euroeyes International Eye Clinic Ltd is a Germany-based company engaged in the optical industry. The Company provides various services for vision correction, such as refractive laser surgery, phakic lens surgery and lens exchange surgery. The Company operates in Germany, Denmark and China.
Calendar
2024-08-27
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
4.95
HKD
Average target price
7.26
HKD
Spread / Average Target
+46.67%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -4.99% | 211M | |
| -21.25% | 2.91B | |
| -20.94% | 2.67B | |
| -25.10% | 323M | |
| -47.38% | 172M | |
| -27.37% | 123M |
- Stock Market
- Equities
- 1846 Stock
